Blue Cross Blue Shield · CPAP APAP · US health-plan appeal rights

CPAP APAP denied as duplicate or overlapping therapy by Blue Cross Blue Shield?

Q: How long do I have to appeal a Blue Cross Blue Shield CPAP APAP denial?

Internal appeal window: Typically 180 days from the denial date. External review window: Typically 60–120 days after the final internal denial. The clock starts from the date on the denial letter.

If two medications appear duplicative on paper but serve different clinical purposes (e.g., short-acting vs long-acting), the appeal needs to spell out the clinical rationale for both.

By Michael John Ryan, Founder & Privacy Officer, DenialHelp, LLC

Last reviewed 2026-05-10

Policy data current as of 2026-04-26

US health-plan appeal rights

Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules

Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.

Internal appeal window

Typically 180 days from the denial date

External review window

Typically 60–120 days after the final internal denial

What Blue Cross Blue Shield typically requires

Blue Cross Blue Shield's specific coverage criteria for cpap apap are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

Source policy: Anthem BCBS clinical guideline (PAP) + the applicable clinical guideline (Polysomnography) + the applicable clinical guideline (HGNS)

The Blue Cross Blue Shield angle on CPAP APAP

## Why BCBS Denied Your CPAP/APAP as Duplicate Therapy

A duplicate-therapy denial for a CPAP (continuous positive airway pressure) or APAP (auto-titrating positive airway pressure) device means BCBS has determined that you already have an approved or covered device that serves the same clinical function, or that another treatment modality already on your coverage has been classified as addressing the same condition. This can happen when a patient transitions from one PAP device to another, when a replacement device is requested before the plan's coverage interval has elapsed, or when a device upgrade is sought.

These denials are frequently resolved when your prescriber documents why the current or previously approved therapy is inadequate — because of equipment failure, documented adherence problems tied to the device type, a change in your clinical status, or a clinical determination that APAP titration is necessary where a fixed-pressure CPAP is not providing adequate therapy.

## Your Federal Appeal Rights

Internal appeal (ACA §2719 / ERISA §503): You are entitled to a full-and-fair internal review. Submit your appeal within the timeframe on your denial notice — typically 180 days.
External review: After a final internal denial, you may request independent external review within approximately four months. The independent review organization (IRO) decision is binding on the plan.
Expedited review: If delay poses a serious risk to your health (for example, untreated obstructive sleep apnea with a documented clinical complication), you may request expedited internal review (typically 72 hours) and concurrent expedited external review.

## How to Build Your Appeal

1. Document why the existing or prior therapy is not adequate. This is the central argument. Your prescriber or the ordering sleep physician should provide a letter explaining — with chart entries — why the device already on record is not providing sufficient therapy. This may include: documented download data from the existing device showing inadequate pressure delivery or persistent events, equipment failure records, adherence data, or a change in your clinical presentation requiring a different titration mode.

2. Obtain a sleep study or follow-up data supporting the new device. If a diagnostic study or device-download report supports the clinical need for APAP versus CPAP (or vice versa), include it. Objective data showing residual apnea-hypopnea events, mask leak, or treatment failure is particularly persuasive.

3. Request the BCBS duplicate-therapy policy. Obtain the specific coverage or medical policy applied to this denial. Copy each criterion into your appeal and respond with chart-based facts.

4. Reference applicable clinical guidelines. Your prescriber's letter should note, where applicable, that the transition from one PAP modality to another is supported by applicable sleep medicine society guidance (e.g., from the American Academy of Sleep Medicine), referencing the organization generically.

5. Include all supporting documentation. Device compliance reports, diagnostic sleep study results, prescriber visit notes, and any equipment repair or replacement records all strengthen the appeal.

## Timeline

File the internal appeal promptly within the window on your denial notice.
After a final internal denial, request external review within approximately four months.

DenialHelp can help you draft a structured appeal letter built from your device data and clinical records.

Next steps

Find the date on the denial letter — your appeal window starts there.
Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
Request the insurer's claim file in writing — they must provide it.
Submit your appeal in writing with new clinical evidence and a physician statement.

Get the letter drafted

DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.

Start my appeal — $30 with code SEO25 →

Related appeal guides

Other Blue Cross Blue Shield appeals

Other insurers on CPAP APAP

Other denial reasons for Blue Cross Blue Shield CPAP APAP

denied as not medically necessary denied for failing step therapy denied as non-formulary denied for missing prior authorization denied as experimental or investigational

This guide describes general US federal appeal rights based on Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules. Your specific plan documents (Summary of Benefits and Coverage, Evidence of Coverage) override anything here. DenialHelp is not your lawyer and not your physician — we draft appeal letters that your physician signs. Outcomes depend on your insurer's decision and factors outside our control. Reviewed by Michael John Ryan on 2026-05-10. Editorial standards: denialhelp.com/authors.